Modest Amusement Indeed | GenomeWeb

In the September/October issue of Technology Review, Duke's Misha Angrist says that the authorities in California and New York were "wrongheaded and arrogant" to insist that the services offered by personal genomics companies need to have a physician gatekeeper. True, the tests haven't been validated, and Angrist says that will take years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.